|
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
|
5R21CA189990-02
|
$232,616
|
$232,616
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatr
|
1R21CA198392-01
|
$199,665
|
$49,916
|
OTTO, MARIO
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$3,125
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$6,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$385,219
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-05
|
$325,282
|
$325,282
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$189,310
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$6,729
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$10,983
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
|
5R01CA143107-06
|
$237,269
|
$118,635
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$359,862
|
$359,862
|
Khan, Javed
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$376,957
|
$37,696
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-41S1
|
$120,000
|
$4,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S2
|
$60,000
|
$2,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S3
|
$125,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S4
|
$157,133
|
$6,285
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-41
|
$3,792,720
|
$151,709
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$1,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$2,499
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$3,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$3,172
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$145,859
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-33S1
|
$62,500
|
$5,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
$202,332
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-36S1
|
$43,749
|
$875
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-36S2
|
$130,627
|
$2,613
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-36
|
$6,012,603
|
$120,252
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-05
|
$654,642
|
$477,889
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-21
|
$4,271,782
|
$427,178
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$481,042
|
$24,052
|
Widemann, Brigitte
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$5,179
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$18,339
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$47,505
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$73,422
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$5,468
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$62,286
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$5,892
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$1,926,424
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death
|
1F32CA199716-01
|
$55,733
|
$27,867
|
GUARNIERI, ANNA
|
UNIVERSITY OF COLORADO
|
|
Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma
|
ZIA BC 010806
|
$179,931
|
$89,965
|
Khan, Javed
|
CCR (NCI)
|
|
Development of antibody-based cancer therapies
|
ZIA BC 010891
|
$770,281
|
$770,281
|
Ho, Mitchell
|
CCR (NCI)
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-24
|
$636,692
|
$318,346
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Engineering a supramolecular platinum nanoparticle for pediatric cancer
|
5R21CA186009-02
|
$181,037
|
$90,519
|
SENGUPTA, SHILADITYA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-13
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
EORTC HEADQUARTERS
|
5U10CA011488-45
|
$250,025
|
$5,001
|
LACOMBE, DENIS
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Epigenetic Regulation of Neuroblast Differentiation
|
1F31CA192558-01
|
$33,544
|
$33,544
|
GAVIGLIO, ANGELA
|
DUKE UNIVERSITY
|
|
Exploring the oncogenic potential of human APOBEC3 cytosine deaminases
|
1R21CA185799-01A1
|
$182,700
|
$62,118
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Genetic network analysis of cancer targets
|
5U01CA176287-03
|
$308,328
|
$308,328
|
WEISS, WILLIAM
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Neuroblastoma for this search: $19,155,625
|